These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

174 related items for PubMed ID: 110570

  • 1. Effects of vasoactive intestinal polypeptide (VIP) on lower esophageal sphincter in awake baboons: comparison with glucagon and secretin.
    Siegel SR, Brown FC, Castell DO, Johnson LF, Said SI.
    Dig Dis Sci; 1979 May; 24(5):345-9. PubMed ID: 110570
    [Abstract] [Full Text] [Related]

  • 2. Effect of glucagon, secretin, and vasoactive intestinal polypeptide on the feline lower esophageal sphincter: mechanisms of action.
    Behar J, Field S, Marin C.
    Gastroenterology; 1979 Nov; 77(5):1001-7. PubMed ID: 226449
    [No Abstract] [Full Text] [Related]

  • 3. Effects of vasoactive intestinal peptide on resting and pentagastrin-stimulated lower esophageal sphincter pressure.
    Domschke W, Lux G, Domschke S, Strunz U, Bloom SR, Wünsch E.
    Gastroenterology; 1978 Jul; 75(1):9-12. PubMed ID: 401103
    [Abstract] [Full Text] [Related]

  • 4. Effects of glucagon, secretin, and vasoactive intestinal polypeptide on gastric somatostatin and gastrin release from isolated perfused rat stomach.
    Chiba T, Taminato T, Kadowaki S, Abe H, Chihara K, Seino Y, Matsukura S, Fujita T.
    Gastroenterology; 1980 Jul; 79(1):67-71. PubMed ID: 6103859
    [Abstract] [Full Text] [Related]

  • 5. Lower esophageal sphincter responses to enteric hormones in two patients with Zollinger-Ellison syndrome.
    Wu WC, Hogan WJ, Whalen GE, Hoke SE, Go VL, Kalkhoff RK.
    Am J Dig Dis; 1975 Aug; 20(8):716-20. PubMed ID: 1155411
    [Abstract] [Full Text] [Related]

  • 6. Assessment of the effects of vasoactive intestinal peptide (VIP) on blood flow through and salivation of the dog salivary gland in comparison with those of secretin, glucagon and acetylcholine.
    Shimizu T, Taira N.
    Br J Pharmacol; 1979 Apr; 65(4):683-7. PubMed ID: 435691
    [Abstract] [Full Text] [Related]

  • 7. The effects of peptide hormones on the pressure profile of the lower esophageal sphincter (LES) in dogs.
    Waldeck F, Jennewein HM.
    Pflugers Arch; 1972 Apr; 332():Suppl 332:R24. PubMed ID: 5065990
    [No Abstract] [Full Text] [Related]

  • 8. Secretin and VIP-stimulated adenylate cyclase from rat heart. I. General properties and structural requirements for enzyme activation.
    Chatelain P, Robberecht P, De Neef P, Deschodt-Lanckman M, König W, Christophe J.
    Pflugers Arch; 1980 Dec; 389(1):21-7. PubMed ID: 7193463
    [Abstract] [Full Text] [Related]

  • 9. Stimulation of retinal adenylate cyclase by vasoactive intestinal peptide (VIP).
    Longshore MA, Makman MH.
    Eur J Pharmacol; 1981 Mar 12; 70(2):237-40. PubMed ID: 7262187
    [Abstract] [Full Text] [Related]

  • 10. Effects of synthetic vasoactive intestinal peptide (VIP), secretin and their partial sequences on gastric secretion.
    Makhlouf GM, Zfass AM, Said SI, Schebalin M.
    Proc Soc Exp Biol Med; 1978 Apr 12; 157(4):565-8. PubMed ID: 349569
    [No Abstract] [Full Text] [Related]

  • 11. The interaction of glucagon and pentagastrin on the lower oesophageal sphincter in man and dog.
    Jennewein HM, Waldeck F, Siewert R, Weiser F, Thimm R.
    Gut; 1973 Nov 12; 14(11):861-4. PubMed ID: 4761605
    [Abstract] [Full Text] [Related]

  • 12. Effects of endogenous hyperglucagonemia on lower esophageal sphincter pressure and gastric acid secretion.
    Tolin RD, Boden G, Fisher RS.
    Dig Dis Sci; 1979 Apr 12; 24(4):296-304. PubMed ID: 222559
    [Abstract] [Full Text] [Related]

  • 13. Effects of gastrointestinal and related hormones on glycogenolysis and gluconeogenesis in cultured liver cells.
    Matsumura M, Akiyoshi H, Fujii S.
    J Biochem; 1977 Oct 12; 82(4):1073-6. PubMed ID: 924981
    [Abstract] [Full Text] [Related]

  • 14. Vasoactive intestinal peptide- and adrenocorticotropin-stimulated adenyl cyclase in cultured adrenal tumor cells: evidence for a specific vasoactive intestinal peptide receptor.
    Birnbaum RS, Alfonzo M, Kowal J.
    Endocrinology; 1980 Apr 12; 106(4):1270-5. PubMed ID: 6244149
    [Abstract] [Full Text] [Related]

  • 15. Activation of human adenylate cyclase in the upper gastrointestinal tract by vasoactive intestinal polypeptide.
    Simon B, Kather H.
    Gastroenterology; 1978 Apr 12; 74(4):722-5. PubMed ID: 204535
    [Abstract] [Full Text] [Related]

  • 16. Secretin and vasoactive intestinal peptide acutely increase tyrosine 3-monooxygenase in the rat superior cervical ganglion.
    Ip NY, Ho CK, Zigmond RE.
    Proc Natl Acad Sci U S A; 1982 Dec 12; 79(23):7566-9. PubMed ID: 6130526
    [Abstract] [Full Text] [Related]

  • 17. Effect of motilin on the lower esophageal sphincter of the opossum.
    Gutierrez JG, Thanik KD, Chey WY, Yajima H.
    Am J Dig Dis; 1977 May 12; 22(5):402-5. PubMed ID: 855853
    [Abstract] [Full Text] [Related]

  • 18. [Gastrointestinal hormones and lower esophageal sphincter].
    Siewert R.
    Z Gastroenterol; 1976 Mar 12; 14 Suppl():160-7. PubMed ID: 960915
    [Abstract] [Full Text] [Related]

  • 19. Gastric inhibitory peptide (GIP), pancreatic glucagon and vasoactive intestinal peptide (VIP) are cAMP-inducing hormones in the human gastric cancer cell line HGT-1. Homologous desensitization of VIP receptor activity.
    Gespach C, Emami S, Rosselin G.
    Biochem Biophys Res Commun; 1984 Apr 30; 120(2):641-9. PubMed ID: 6329177
    [Abstract] [Full Text] [Related]

  • 20. Effects of gastrointestinal hormones and carbamylcholine on cAMP accumulation in isolated pancreatic duct fragments from the rat.
    Fölsch UR, Fischer H, Söling HD, Creutzfeldt W.
    Digestion; 1980 Apr 30; 20(4):277-92. PubMed ID: 6248407
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.